Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-003780
Filing Date
2017-02-13
Accepted
2017-02-13 16:05:29
Documents
1
Period of Report
2017-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3383
  Complete submission text file 0000899243-17-003780.txt   4732
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Issuer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 ELLIOTT AVE. W. SUITE 400 SEATTLE WA 98119
Business Address
Telling Fred (Reporting) CIK: 0001382225 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32188 | Film No.: 17599028